Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Health Catalyst (HCAT) Net Margin (2018 - 2025)

Health Catalyst's Net Margin history spans 8 years, with the latest figure at 121.89% for Q4 2025.

  • For Q4 2025, Net Margin fell 9592.0% year-over-year to 121.89%; the TTM value through Dec 2025 reached 57.2%, down 3453.0%, while the annual FY2025 figure was 57.2%, 3453.0% down from the prior year.
  • Net Margin reached 121.89% in Q4 2025 per HCAT's latest filing, down from 29.12% in the prior quarter.
  • In the past five years, Net Margin ranged from a high of 17.81% in Q2 2024 to a low of 121.89% in Q4 2025.
  • Average Net Margin over 5 years is 46.61%, with a median of 44.74% recorded in 2023.
  • Peak YoY movement for Net Margin: surged 3704bps in 2023, then tumbled -9592bps in 2025.
  • A 5-year view of Net Margin shows it stood at 75.63% in 2021, then soared by 32bps to 51.68% in 2022, then grew by 22bps to 40.37% in 2023, then soared by 36bps to 25.97% in 2024, then plummeted by -369bps to 121.89% in 2025.
  • Per Business Quant, the three most recent readings for HCAT's Net Margin are 121.89% (Q4 2025), 29.12% (Q3 2025), and 50.76% (Q2 2025).